Patent details
EP3956326 Title: (R)-3-(3-CHLORO-5-FLUORO-2-((4-(1H-PYRAZOL-1-YL)-2-METHYLQUINOLIN-8-YLOXY)METHYL)PHENYL)MORPHOLINE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ (BK) B2 RECEPTOR ANTAGONIST FOR TREATING SKIN DISEASES
Basic Information
- Publication number:
- EP3956326
- PCT Application Number:
- EP2020064379
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP207321175
- PCT Publication Number:
- WO2020234480
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- (R)-3-(3-CHLORO-5-FLUORO-2-((4-(1H-PYRAZOL-1-YL)-2-METHYLQUINOLIN-8-YLOXY)METHYL)PHENYL)MORPHOLINE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ (BK) B2 RECEPTOR ANTAGONIST FOR TREATING SKIN DISEASES
- French Title of Invention:
- DÉRIVÉS DE (R)-3-(3-CHLORO-5-FLUORO-2-((4-(1H-PYRAZOL-1-YL)-2-MÉTHYLQUINOLIN-8-YLOXY)MÉTHYL)PHÉNYL)MORPHOLINE ET COMPOSÉS SIMILAIRES EN TANT QU'ANTAGONISTES DU RÉCEPTEUR DE LA BRADYKININ (BK) B2 POUR LE TRAITEMENT DE MALADIES DE LA PEAU
- German Title of Invention:
- (R)-3-(3-CHLORO-5-FLUORO-2-((4-(1H-PYRAZOL-1-YL)-2-METHYLQUINOLIN-8-YLOXY)METHYL)PHENYL)MORPHOLIN-DERIVATE UND ÄHNLICHE VERBINDUNGEN ALS BRADYKININ (BK) B2 REZEPTOR ANTAGONISTEN ZUR BEHANDLUNG VON HAUTERKRANKUNGEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 19/07/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 25/07/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 28/06/2023
- Unitary Effect Registration Date:
- 25/07/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 25/05/2020
- Grant date:
- 28/06/2023
- EP Publication Date:
- 23/02/2022
- PCT Publication Date:
- 26/11/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 28/06/2023
- EP B1 Publication Date:
- 28/06/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 25/05/2040
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 21/06/2023
- Name:
- Pharvaris GmbH
- Address:
- Grafenauweg 8, 6300 Zug, Switzerland (CH)
Inventor
1
- Name:
- AMBROSI, Horst-Dieter
- Address:
- Germany (DE)
2
- Name:
- HAUSTEDT, Lars Ole
- Address:
- Germany (DE)
3
- Name:
- GIBSON, Christoph
- Address:
- Germany (DE)
4
- Name:
- SAUPE, Joern
- Address:
- Germany (DE)
Priority
- Priority Number:
- 19176229
- Priority Date:
- 23/05/2019
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- C07D 413/14; A61K 31/4709; A61K 31/5377; A61K 31/4155; A61K 31/4196; A61K 31/422; A61P 1/16; A61P 5/00; A61P 9/00; A61P 11/00; A61P 13/00; A61P 13/12; A61P 15/00; A61P 17/00; A61P 25/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202326
- Publication date:
- 28/06/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202334
- Publication date:
- 23/08/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202334
- Publication date:
- 23/08/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|